000 | 01644 a2200421 4500 | ||
---|---|---|---|
005 | 20250516060609.0 | ||
264 | 0 | _c20120809 | |
008 | 201208s 0 0 spa d | ||
022 | _a1578-8989 | ||
024 | 7 |
_a10.1016/j.medcli.2011.07.014 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _ade la Haba-Rodríguez, Juan R | |
245 | 0 | 0 |
_a[ABCB1 polymorphisms in patients with Charcot-Marie-Tooth disease. A possible relationship with neurotoxicity due to cytostatic treatment]. _h[electronic resource] |
260 |
_bMedicina clinica _cApr 2012 |
||
300 |
_a456-7 p. _bdigital |
||
500 | _aPublication Type: Letter | ||
650 | 0 | 4 |
_aAdenocarcinoma _xcomplications |
650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
650 | 0 | 4 |
_aBreast Neoplasms _xcomplications |
650 | 0 | 4 |
_aCharcot-Marie-Tooth Disease _xcomplications |
650 | 0 | 4 |
_aColonic Neoplasms _xcomplications |
650 | 0 | 4 |
_aCytostatic Agents _xadverse effects |
650 | 0 | 4 | _aDisease Susceptibility |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGenotype |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMultidrug Resistance-Associated Proteins _xgenetics |
650 | 0 | 4 |
_aOrganoplatinum Compounds _xadverse effects |
650 | 0 | 4 | _aOxaliplatin |
650 | 0 | 4 |
_aPaclitaxel _xadverse effects |
650 | 0 | 4 |
_aPeripheral Nervous System Diseases _xchemically induced |
650 | 0 | 4 | _aPolymorphism, Single Nucleotide |
700 | 1 | _aOrtiz-Morales, María José | |
700 | 1 | _aGómez-España, María Auxiliadora | |
700 | 1 | _aAranda Aguilar, Enrique | |
773 | 0 |
_tMedicina clinica _gvol. 138 _gno. 10 _gp. 456-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.medcli.2011.07.014 _zAvailable from publisher's website |
999 |
_c21216677 _d21216677 |